MyFinsight
Home
Blog
About
Contact
Net decrease in
cash, cash...
-$108,531K
Proceeds from issuance of
debt
$134,673K
Payments of deferred
financing and refinancing...
-$72,991K
Tax and other
distributions to...
-$31,678K
Proceeds from alliance
party
$510K
Proceeds from exercise of
stock options
$38K
Net income
$78,000K
Trade accounts
receivable, net
-$44,013K
Depreciation and
amortization
$43,191K
Inventory provision
$13,353K
Stock-based compensation
$8,816K
Unrealized foreign
currency loss (gain)
-$8,215K
Amortization of debt issuance
costs and discount
$3,890K
Loss on refinancing
-$3,510K
Reclassification of cash flow
hedge
-$2,878K
Other operating
charges and credits, net
-$1,486K
something is missing
$1,379K
Net cash used in
financing activities
-$59,055K
Net cash (used in)
provided by operating...
-$26,743K
Net cash used in
investing activities
-$21,710K
Effect of foreign
exchange rate on cash
-$1,023K
Canceled cashflow
$239,890K
Canceled cashflow
$207,352K
Canceled cashflow
$1,379K
Payments of principal on
debt, revolving...
$140,842K
Accounts payable,
accrued expenses and...
-$124,578K
Purchases of property,
plant and equipment
$8,175K
Acquisition of intangible
assets
$7,850K
Deposits for future
acquisition of property,...
$5,685K
something is missing
-$113,798K
Employee payroll tax
withholding on restricted...
$44,305K
Inventories
$54,959K
Related party payables
-$41,102K
Prepaid expenses, other
current assets and other...
$13,400K
Related party
receivables
$56K
Proceeds from sale of
property, plant and...
-$1,379K
Back
Back
Cash Flow
Amneal Pharmaceuticals, Inc. (AMRX)
Amneal Pharmaceuticals, Inc. (AMRX)
source: myfinsight.com